AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.
In the study of 30,000 people, the vaccine was 79% effective at preventing symptomatic cases of COVID-19 — including in older adults. There were no severe illnesses or hospitalizations among vaccinated volunteers, compared with five such cases in participants who received dummy shots — a small number, but consistent with findings from Britain and other countries that the vaccine protects against the worst of the disease.
[ Ссылка ]
Is the AstraZeneca vaccine safe?
Теги
AstraZenecaCOVIDCharlotteCoronavirusDataDoctorExpertHealthLocalNewsNorth CarolinaSafeStudyVaccinationVaccineWCNCastrazeneca vaccinecovid-19 vaccinecoronavirus pandemicus newsworld newscoronavirus vaccineastrazeneca covid-19 vaccineoxford-astrazeneca covid-19 vaccineastrazeneca concernscovid-19 vaccine updatecovid-19 vaccine newscovid-19 vaccine shotastrazeneca vaccine covid 19 updatecovid-19 vaccine information
